| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.10e-06 | 12 | 140 | 4 | GO:0017154 | |
| GeneOntologyMolecularFunction | protein antigen binding | 1.77e-04 | 16 | 140 | 3 | GO:1990405 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor | 2.90e-04 | 4 | 140 | 2 | GO:0016647 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 2.90e-04 | 4 | 140 | 2 | GO:0034617 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | KIF13B RELN HECW1 NRDC MYCBP2 ENPP1 APBB2 POU4F3 PLXND1 ITGA4 IDUA NEDD4 CRYAA PTK2B PTPRD CELSR2 NBEAL2 MYPN CDH6 PLXNA1 ZMYM4 PLXNA2 CNTN2 PLXNB1 | 1.21e-06 | 1194 | 138 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | KIF13B RELN HECW1 NRDC MYCBP2 APBB2 POU4F3 PLXND1 ITGA4 NEDD4 PTPRD CELSR2 MYPN PLXNA1 PLXNA2 CNTN2 PLXNB1 | 1.08e-05 | 748 | 138 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection development | KIF13B RELN TOX HECW1 NRDC MYCBP2 ENPP1 APBB2 HMGB1 POU4F3 PLXND1 ITGA4 NEDD4 PTK2B ARID1B PTPRD CELSR2 PJVK MYPN PLXNA1 PLXNA2 CNTN2 PLXNB1 | 1.41e-05 | 1285 | 138 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | KIF13B RELN HECW1 NRDC MYCBP2 APBB2 POU4F3 PLXND1 ITGA4 NEDD4 PTPRD CELSR2 MYPN PLXNA1 PLXNA2 CNTN2 PLXNB1 | 2.63e-05 | 802 | 138 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | KIF13B RELN HECW1 NRDC MYCBP2 APBB2 POU4F3 PLXND1 ITGA4 NEDD4 PTPRD CELSR2 MYPN PLXNA1 PLXNA2 CNTN2 PLXNB1 | 3.43e-05 | 819 | 138 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuron development | KIF13B RELN TOX HECW1 NRDC MYCBP2 ENPP1 APBB2 HMGB1 POU4F3 PLXND1 ITGA4 NEDD4 PTK2B TH ARID1B PTPRD CELSR2 PJVK MYPN PLXNA1 PLXNA2 CNTN2 PLXNB1 | 3.70e-05 | 1463 | 138 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | KIF13B RELN HECW1 NRDC MYCBP2 APBB2 POU4F3 PLXND1 ITGA4 NEDD4 PTPRD CELSR2 MYPN PLXNA1 PLXNA2 CNTN2 PLXNB1 | 3.81e-05 | 826 | 138 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | KIF13B RELN ABR HECW1 NRDC ADGRB2 HMGB1 PLXND1 PGK1 CEMIP2 NEDD4 OPRPN PTK2B PTPRD IL1A PLXNA1 ZMYM4 PLXNA2 CNTN2 PLXNB1 | 3.87e-05 | 1090 | 138 | 20 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | KIF13B RELN TOX HECW1 NRDC MYCBP2 PLXND1 NEDD4 PTK2B PTPRD PLXNA1 PLXNA2 CNTN2 PLXNB1 | 6.34e-05 | 612 | 138 | 14 | GO:0010975 |
| GeneOntologyBiologicalProcess | axon development | KIF13B RELN NRDC MYCBP2 ENPP1 APBB2 POU4F3 PLXND1 ITGA4 MYPN PLXNA1 PLXNA2 CNTN2 PLXNB1 | 1.05e-04 | 642 | 138 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | KIF13B RELN NRDC MYCBP2 APBB2 POU4F3 PLXND1 ITGA4 MYPN PLXNA1 PLXNA2 CNTN2 PLXNB1 | 1.12e-04 | 566 | 138 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | salivary gland development | 1.93e-04 | 43 | 138 | 4 | GO:0007431 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 2.02e-04 | 302 | 138 | 9 | GO:0022604 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.31e-06 | 13 | 140 | 4 | GO:0002116 | |
| Domain | Plexin_cytopl | 3.49e-07 | 9 | 138 | 4 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 3.49e-07 | 9 | 138 | 4 | IPR013548 | |
| Domain | Plexin | 3.49e-07 | 9 | 138 | 4 | IPR031148 | |
| Domain | IPT | 4.39e-05 | 27 | 138 | 4 | SM00429 | |
| Domain | Cl_channel-K | 5.42e-05 | 2 | 138 | 2 | IPR002250 | |
| Domain | Semap_dom | 7.69e-05 | 31 | 138 | 4 | IPR001627 | |
| Domain | SEMA | 7.69e-05 | 31 | 138 | 4 | PS51004 | |
| Domain | TIG | 7.69e-05 | 31 | 138 | 4 | PF01833 | |
| Domain | Sema | 7.69e-05 | 31 | 138 | 4 | SM00630 | |
| Domain | Sema | 7.69e-05 | 31 | 138 | 4 | PF01403 | |
| Domain | IPT | 8.74e-05 | 32 | 138 | 4 | IPR002909 | |
| Domain | Plexin_repeat | 8.74e-05 | 32 | 138 | 4 | IPR002165 | |
| Domain | PSI | 8.74e-05 | 32 | 138 | 4 | PF01437 | |
| Domain | PSI | 3.08e-04 | 44 | 138 | 4 | IPR016201 | |
| Domain | PSI | 3.66e-04 | 46 | 138 | 4 | SM00423 | |
| Domain | Rho_GTPase_activation_prot | 4.91e-04 | 88 | 138 | 5 | IPR008936 | |
| Pubmed | 6.07e-09 | 17 | 141 | 5 | 11683995 | ||
| Pubmed | KIF13B DLGAP2 ABR HECW1 MYCBP2 HNRNPM ADGRB2 BCOR VIRMA PGK1 NEDD4 PPP2CB MDN1 PTPRD CELSR2 FRMPD3 CTNND1 SLC4A4 EPB41L1 | 1.40e-08 | 963 | 141 | 19 | 28671696 | |
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 1.25e-07 | 12 | 141 | 4 | 21270798 | |
| Pubmed | 1.80e-07 | 13 | 141 | 4 | 10520995 | ||
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 2.60e-07 | 4 | 141 | 3 | 8570614 | |
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 5.91e-07 | 17 | 141 | 4 | 17626059 | |
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 20100830 | ||
| Pubmed | 2.27e-06 | 52 | 141 | 5 | 26633812 | ||
| Pubmed | Presenilin 1 in migration and morphogenesis in the central nervous system. | 3.06e-06 | 25 | 141 | 4 | 15163631 | |
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 15661641 | ||
| Pubmed | 5.38e-06 | 9 | 141 | 3 | 19909241 | ||
| Pubmed | MYCBP2 RBBP5 PPHLN1 CCDC141 ARID1B PIK3C2A EIF4B MYPN PUM3 TRIM38 ZMYM4 | 6.30e-06 | 497 | 141 | 11 | 23414517 | |
| Pubmed | Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. | 7.67e-06 | 10 | 141 | 3 | 16407979 | |
| Pubmed | 9.12e-06 | 251 | 141 | 8 | 29031500 | ||
| Pubmed | 9.51e-06 | 119 | 141 | 6 | 24162774 | ||
| Pubmed | A forward genetic screen in mice identifies mutants with abnormal cortical patterning. | 1.05e-05 | 11 | 141 | 3 | 23968836 | |
| Pubmed | Active intermixing of indirect and direct neurons builds the striatal mosaic. | 1.05e-05 | 11 | 141 | 3 | 30413696 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 1.35e-05 | 265 | 141 | 8 | 19240061 | |
| Pubmed | 1.40e-05 | 12 | 141 | 3 | 25839327 | ||
| Pubmed | Plexin/neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A. | 1.63e-05 | 2 | 141 | 2 | 10781943 | |
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 1.63e-05 | 2 | 141 | 2 | 2555176 | |
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 1.63e-05 | 2 | 141 | 2 | 27335120 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 8812470 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25919862 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 11751260 | ||
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 1.63e-05 | 2 | 141 | 2 | 38069401 | |
| Pubmed | Plexin-A1 and plexin-B1 specifically interact at their cytoplasmic domains. | 1.63e-05 | 2 | 141 | 2 | 12559962 | |
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 1.63e-05 | 2 | 141 | 2 | 20805576 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20663872 | ||
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 1.63e-05 | 2 | 141 | 2 | 15044642 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 11113010 | ||
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 1.63e-05 | 2 | 141 | 2 | 8041726 | |
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 1.63e-05 | 2 | 141 | 2 | 18648499 | |
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 1.63e-05 | 2 | 141 | 2 | 8544406 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23782844 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24863058 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 1.63e-05 | 2 | 141 | 2 | 9916798 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 9916791 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 26126547 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10543450 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 16920974 | ||
| Pubmed | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | 1.63e-05 | 2 | 141 | 2 | 34902541 | |
| Pubmed | Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. | 1.63e-05 | 2 | 141 | 2 | 2837763 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14734633 | ||
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 1.63e-05 | 2 | 141 | 2 | 1846293 | |
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 1.63e-05 | 2 | 141 | 2 | 27096707 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 18292234 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 33973242 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 33040644 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 11014860 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | KIF13B FGFRL1 CEMIP2 CELSR2 SLC16A1 NBEAL2 CTNND1 PLXNA1 PLXNA2 EPB41L1 PLXNB1 | 2.21e-05 | 569 | 141 | 11 | 30639242 |
| Pubmed | TOX ASH1L HMGB1 KDM5D ZDHHC1 CXXC1 NUFIP1 BBX SCAPER UTY PLXNA1 PLXNA2 ZC3HAV1 | 2.69e-05 | 808 | 141 | 13 | 20412781 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TPST1 GLT8D1 GPAA1 MYCBP2 ENPP1 RNF213 PLXND1 ERGIC2 ELAC2 CEMIP2 IGSF10 CELSR2 SCAPER QSOX2 PLXNA1 PLXNB1 | 3.12e-05 | 1201 | 141 | 16 | 35696571 |
| Pubmed | 3.51e-05 | 16 | 141 | 3 | 17356169 | ||
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 3.51e-05 | 16 | 141 | 3 | 18489001 | |
| Pubmed | 3.51e-05 | 16 | 141 | 3 | 19948886 | ||
| Pubmed | 4.03e-05 | 47 | 141 | 4 | 35462405 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 27397516 | ||
| Pubmed | Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional. | 4.88e-05 | 3 | 141 | 2 | 26013830 | |
| Pubmed | Barttin increases surface expression and changes current properties of ClC-K channels. | 4.88e-05 | 3 | 141 | 2 | 12111250 | |
| Pubmed | Population genetic implications from sequence variation in four Y chromosome genes. | 4.88e-05 | 3 | 141 | 2 | 10861003 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 26940976 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 17510212 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 29091353 | ||
| Pubmed | Plexins promote Hedgehog signaling through their cytoplasmic GAP activity. | 4.88e-05 | 3 | 141 | 2 | 36169302 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 7510677 | ||
| Pubmed | Barttin modulates trafficking and function of ClC-K channels. | 4.88e-05 | 3 | 141 | 2 | 16849430 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 18094726 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 10982849 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 8806646 | ||
| Pubmed | The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. | 4.88e-05 | 3 | 141 | 2 | 8206937 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 18625214 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 4.88e-05 | 3 | 141 | 2 | 11241833 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 20356833 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 21871094 | ||
| Pubmed | Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. | 4.88e-05 | 3 | 141 | 2 | 11734858 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 10441131 | ||
| Pubmed | Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function. | 4.88e-05 | 3 | 141 | 2 | 23341017 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 8383590 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 15252037 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B MYCBP2 VIRMA NEDD4 PTK2B MDN1 RESF1 PIK3C2A SLC16A1 EIF4B CTNND1 EPB41L1 ZC3HAV1 | 5.16e-05 | 861 | 141 | 13 | 36931259 |
| Pubmed | PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. | 6.03e-05 | 19 | 141 | 3 | 15239958 | |
| Pubmed | NRDC RBBP5 RBL1 ENPP1 ERGIC2 CEMIP2 ZBED1 QSOX2 EPB41L1 PLXNB1 ZC3HAV1 | 7.33e-05 | 650 | 141 | 11 | 38777146 | |
| Pubmed | Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function. | 8.22e-05 | 21 | 141 | 3 | 21835343 | |
| Pubmed | GLT8D1 ABR GPAA1 MYCBP2 INPP5K HNRNPM RNF213 ERGIC2 ITGA4 PGK1 MDN1 PIK3C2A SLC16A1 PARP16 NBEAL2 | 8.42e-05 | 1168 | 141 | 15 | 19946888 | |
| Pubmed | A dynamic equilibrium between CDKs and PP2A modulates phosphorylation of pRB, p107 and p130. | 9.74e-05 | 4 | 141 | 2 | 15467457 | |
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 9598304 | ||
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 21454489 | ||
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 11306810 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 9.74e-05 | 4 | 141 | 2 | 25518740 | |
| Pubmed | Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse. | 9.74e-05 | 4 | 141 | 2 | 21998041 | |
| Pubmed | Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. | 9.74e-05 | 4 | 141 | 2 | 7616230 | |
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 9920888 | ||
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 20877282 | ||
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 22024150 | ||
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 10725340 | ||
| Pubmed | Unconventional Pathways of Secretion Contribute to Inflammation. | 9.74e-05 | 4 | 141 | 2 | 28067797 | |
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 17652939 | ||
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 36103834 | ||
| Pubmed | 9.74e-05 | 4 | 141 | 2 | 11371618 | ||
| GeneFamily | Plexins | 8.46e-08 | 9 | 94 | 4 | 683 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 6.63e-06 | 51 | 94 | 5 | 870 | |
| GeneFamily | Chloride voltage-gated channels | 1.17e-03 | 10 | 94 | 2 | 302 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.53e-03 | 161 | 94 | 5 | 593 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.01e-03 | 13 | 94 | 2 | 693 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.24e-03 | 50 | 94 | 3 | 1293 | |
| GeneFamily | AT-rich interaction domain containing | 2.69e-03 | 15 | 94 | 2 | 418 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.46e-03 | 17 | 94 | 2 | 684 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 4.78e-03 | 20 | 94 | 2 | 1371 | |
| Coexpression | GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN | 1.20e-05 | 200 | 139 | 8 | M9672 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 1.20e-05 | 200 | 139 | 8 | M8554 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.96e-08 | 172 | 141 | 8 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.57e-06 | 177 | 141 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.96e-06 | 183 | 141 | 7 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 195 | 141 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 195 | 141 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 195 | 141 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.30e-06 | 198 | 141 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-06 | 198 | 141 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 164 | 141 | 6 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 164 | 141 | 6 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 166 | 141 | 6 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-05 | 166 | 141 | 6 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 171 | 141 | 6 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 171 | 141 | 6 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 175 | 141 | 6 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 2.08e-05 | 176 | 141 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.22e-05 | 178 | 141 | 6 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.36e-05 | 180 | 141 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.76e-05 | 185 | 141 | 6 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.93e-05 | 187 | 141 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.93e-05 | 187 | 141 | 6 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 3.11e-05 | 189 | 141 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.30e-05 | 191 | 141 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 191 | 141 | 6 | 08be56a4055a73c920d345fd3b2052a5ccb675d8 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.30e-05 | 191 | 141 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 192 | 141 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | 367C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-05 | 192 | 141 | 6 | 877aaf61d8fc40e7013944a0180306dd0bb0557f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.39e-05 | 192 | 141 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-05 | 193 | 141 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 3.49e-05 | 193 | 141 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-05 | 193 | 141 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.60e-05 | 194 | 141 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-05 | 194 | 141 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 194 | 141 | 6 | 46266d3d9af7000dc1381b1c8e55047193cbcf94 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.70e-05 | 195 | 141 | 6 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 141 | 6 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 141 | 6 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 141 | 6 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.81e-05 | 196 | 141 | 6 | a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 196 | 141 | 6 | 69f27c2668a9f412b2eb6ca83d11b44863209542 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 196 | 141 | 6 | 9d267dd293fde05f04febc0a9d15776c5b782a1c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 196 | 141 | 6 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.92e-05 | 197 | 141 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-05 | 198 | 141 | 6 | 62059185afdf66126a6fbc899ce611c47e7a0feb | |
| ToppCell | AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.03e-05 | 198 | 141 | 6 | 893036558a9ad86b57f9e735df35812e9d18739e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-05 | 198 | 141 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | distal-1-Epithelial-Alveolar_Epithelial_Type_2|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.03e-05 | 198 | 141 | 6 | ce9d6b2a93c7b304414ce1b8b1a09562cf581278 | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 4.14e-05 | 199 | 141 | 6 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.14e-05 | 199 | 141 | 6 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.18e-05 | 121 | 141 | 5 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 8f5d98f962ddd8c4658c89ff8a2894de1228562a | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.26e-05 | 200 | 141 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 345f1eac498cc87fd7bf08e7312608b2d6fe1dd7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.55e-05 | 137 | 141 | 5 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-05 | 140 | 141 | 5 | ab90f6f30d89761687f8836e3d327d143ce49ed4 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.94e-05 | 142 | 141 | 5 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Whrn_Tox2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.24e-05 | 143 | 141 | 5 | 36ce6f163fb33141c86288086c354b91853fad25 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-05 | 145 | 141 | 5 | 186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.05e-04 | 147 | 141 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 151 | 141 | 5 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.43e-04 | 157 | 141 | 5 | 10341ed8cbee0f636770a82cf580f6453bee8596 | |
| ToppCell | droplet-Heart-4Chambers-18m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 84 | 141 | 4 | 57d549d7c5786d2a74601595df3dc3776f8ff6ea | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epi_progenitor|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.52e-04 | 159 | 141 | 5 | a4bfd59c53237964fc24a24de5c1925fdd01db99 | |
| ToppCell | Control-Treg|World / Disease group and Cell class | 1.61e-04 | 161 | 141 | 5 | ead9f5a491321f9e307f7c97e47a4ca124f59bb6 | |
| ToppCell | CD8+_Memory_T_cell-RSV-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.61e-04 | 161 | 141 | 5 | f6d04f67da3557e80f13ef27bfabb94dcd80db2f | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 1.61e-04 | 161 | 141 | 5 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.66e-04 | 162 | 141 | 5 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 162 | 141 | 5 | 448602d5ff8b5be9614c63540a4d0fe6bdaf23b4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 163 | 141 | 5 | 7a04192710f55acf5a4681d5f09942358fdb02ff | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.71e-04 | 163 | 141 | 5 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-04 | 164 | 141 | 5 | 3a4ecc632be003d09b765c992804134348d2278b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.76e-04 | 164 | 141 | 5 | 4b10b78d4d76023c3c5bcd427757218fdd5465ca | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-04 | 165 | 141 | 5 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.81e-04 | 165 | 141 | 5 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.86e-04 | 166 | 141 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-04 | 168 | 141 | 5 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 168 | 141 | 5 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 170 | 141 | 5 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 170 | 141 | 5 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 170 | 141 | 5 | 774b0c1b453e19651f9481dc6bcabac538c5acb7 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 92 | 141 | 4 | ed282f0f3da1593bdec5a2b20af5b8f058574167 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 92 | 141 | 4 | c5f30d58f235f7a72dfe63f58999c4680502576f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.09e-04 | 92 | 141 | 4 | 27072dbf6819dca41e41267dc250abfaaf175b2f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-04 | 172 | 141 | 5 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 172 | 141 | 5 | 51bea97564a33f0060c546c9be4bf8bf8f1660f6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 172 | 141 | 5 | be4dd4ba8d7a651677c797c25fd75f14e627415a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 173 | 141 | 5 | a693772987f1baee533dd0bd285a3c7b5619a73b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-04 | 175 | 141 | 5 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 176 | 141 | 5 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 178 | 141 | 5 | b4e15c176875cd226854a0019495309d02730c42 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 179 | 141 | 5 | 7e6da098976c7801d31dcc0201f813d2bc8b07fc | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 1.17e-05 | 10 | 138 | 3 | DOID:12387 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia | 2.14e-05 | 12 | 138 | 3 | EFO_1001304 | |
| Disease | Bartter disease type 4B | 2.17e-05 | 2 | 138 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 2.17e-05 | 2 | 138 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 2.17e-05 | 2 | 138 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 2.17e-05 | 2 | 138 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 2.17e-05 | 2 | 138 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 2.17e-05 | 2 | 138 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease (implicated_via_orthology) | 2.17e-05 | 2 | 138 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | Kearns-Sayre syndrome | 2.15e-04 | 5 | 138 | 2 | C0022541 | |
| Disease | diabetic angiopathy (implicated_via_orthology) | 3.22e-04 | 6 | 138 | 2 | DOID:11713 (implicated_via_orthology) | |
| Disease | Bartter syndrome | 3.22e-04 | 6 | 138 | 2 | cv:C0004775 | |
| Disease | clostridium difficile infection | 5.95e-04 | 144 | 138 | 5 | EFO_0009130 | |
| Disease | Megaconial Myopathies | 7.65e-04 | 9 | 138 | 2 | C0162668 | |
| Disease | Pleoconial Myopathies | 7.65e-04 | 9 | 138 | 2 | C0162669 | |
| Disease | Luft Disease | 7.65e-04 | 9 | 138 | 2 | C0949496 | |
| Disease | uremia (biomarker_via_orthology) | 9.53e-04 | 10 | 138 | 2 | DOID:4676 (biomarker_via_orthology) | |
| Disease | nephritis (implicated_via_orthology) | 9.53e-04 | 10 | 138 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 32:0 measurement | 1.16e-03 | 11 | 138 | 2 | EFO_0010372 | |
| Disease | Mitochondrial Myopathies | 1.16e-03 | 11 | 138 | 2 | C0162670 | |
| Disease | Myocardial Ischemia | 1.46e-03 | 176 | 138 | 5 | C0151744 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.58e-03 | 49 | 138 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | FVC change measurement, response to placebo | 1.64e-03 | 13 | 138 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | illegal drug consumption | 1.64e-03 | 13 | 138 | 2 | EFO_0005431 | |
| Disease | glucose-dependent insulinotropic peptide measurement | 1.98e-03 | 53 | 138 | 3 | EFO_0008464 | |
| Disease | cognitive decline measurement | 2.10e-03 | 486 | 138 | 8 | EFO_0007710 | |
| Disease | phosphatidylcholine 36:3 measurement | 2.19e-03 | 15 | 138 | 2 | EFO_0010381 | |
| Disease | hypertension (is_implicated_in) | 2.55e-03 | 121 | 138 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | Muscle hypotonia | 2.82e-03 | 17 | 138 | 2 | C0026827 | |
| Disease | alpha-L-iduronidase measurement | 2.82e-03 | 17 | 138 | 2 | EFO_0020139 | |
| Disease | otitis media (biomarker_via_orthology) | 2.82e-03 | 17 | 138 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | esophageal adenocarcinoma | 3.16e-03 | 18 | 138 | 2 | EFO_0000478 | |
| Disease | schizophrenia, inflammatory bowel disease | 3.16e-03 | 18 | 138 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | bitter alcoholic beverage consumption measurement | 3.58e-03 | 133 | 138 | 4 | EFO_0010092 | |
| Disease | Status Epilepticus | 4.02e-03 | 68 | 138 | 3 | C0038220 | |
| Disease | susceptibility to mononucleosis measurement | 4.19e-03 | 69 | 138 | 3 | EFO_0008403 | |
| Disease | hypertension (biomarker_via_orthology) | 4.37e-03 | 227 | 138 | 5 | DOID:10763 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFALKSLTYLSRLFP | 161 | O60507 | |
| PPISFAELKRNTLYF | 841 | Q12979 | |
| NPDPTKYSLYLRFNR | 71 | O60241 | |
| SPSRRFYHNELFRVP | 2731 | Q9NR48 | |
| LPSQPRRTKSFLNYY | 151 | Q92870 | |
| KFNSLPQYSPVTFDR | 696 | Q8WY36 | |
| KLIFSLRDPAYSTFP | 181 | Q53TN4 | |
| KPERFLEISSPFLNY | 501 | Q8N7X0 | |
| DYFFLQPLPTKRRRA | 171 | Q9H175 | |
| RFRLGSYKPVNSVPF | 346 | Q96RQ1 | |
| RKAFRPFTNYSIPTR | 51 | Q8WXA8 | |
| LDPAANYNSPKFRSR | 496 | Q9P1A6 | |
| ATPPFSRQEKFYATL | 2171 | Q8NFD5 | |
| RSGKSQPSYIPFLLR | 2671 | Q9HCU4 | |
| RFRKRPEPSSDYDLS | 1396 | Q6W2J9 | |
| QYFRLFNSTRLPKPS | 216 | P23786 | |
| KPLRAFFSSYLKSLP | 276 | Q6ZRP7 | |
| LALTKSPQAFYRGRP | 91 | Q8WXF3 | |
| VFLDFFTYAPPKLRS | 331 | Q15397 | |
| SFDAPNERPYSLKIR | 81 | Q01151 | |
| PILKPRFYSISSSRD | 901 | P35228 | |
| NTKPIRPRIQYFFAA | 321 | P53985 | |
| LTPFLNPFIYSLRNK | 281 | Q8NGY5 | |
| DRPAPFFERSSSKRY | 411 | Q9H4G0 | |
| PRSAPFSFLSNVKYN | 111 | P01583 | |
| KYPTGIFTRFFLLPN | 206 | Q5VXI9 | |
| PDVLPFALRYFKDTS | 106 | Q9NU22 | |
| PTSSFRNLLKRVYPD | 191 | Q5VTA0 | |
| KRPPSAFFLFCSEYR | 96 | P09429 | |
| NPRLERPYTFKDFVL | 536 | P46934 | |
| LEVYTQSFSRKLPFP | 101 | O43292 | |
| FFTRPFYKALLRLPC | 1361 | Q76N89 | |
| NPTKRYRAFITNIPF | 66 | P52272 | |
| FSSYSRRAKRLQPDP | 206 | Q9BY66 | |
| LSPKRFTFVTPTFYR | 951 | Q9UIW2 | |
| KQDYFPTLSSRKLPR | 191 | O75051 | |
| LSTSRPVPLAVKYFF | 1941 | O43157 | |
| SRFRLDYLPNPQFST | 1166 | Q9Y4D7 | |
| YSFRSAFLTVLPDPK | 346 | Q8N441 | |
| ARRSEFFKTYICLPP | 31 | Q9H6K4 | |
| PFSRLPVDKFLSVFY | 261 | Q8NGD4 | |
| EPILSFSPKTYSFRQ | 1406 | O00443 | |
| RKSVPRGLPYFSVDF | 811 | Q2TBE0 | |
| PKVSYLSEIFPLFRA | 21 | Q8WVB3 | |
| FQPRISYPAKLSFIS | 276 | Q9UN81 | |
| KESVFSPRRYFNIDP | 251 | Q9UQV4 | |
| TFARFYLPILVPSAK | 151 | Q68CQ7 | |
| NSKLRTYLPDFRFTP | 286 | Q13630 | |
| TYLPDFRFTPFKQAV | 291 | Q13630 | |
| RLRPSDVPDKYYSFN | 456 | P22413 | |
| YFAKALESPERPFLA | 196 | P00558 | |
| PVFDLKASLSRPLNY | 356 | Q9BXS6 | |
| TLKYSFLQFDPAPRR | 281 | P62714 | |
| TLKYSFLQFDPAPRR | 281 | P67775 | |
| KAVADPFTYSLLRRP | 286 | Q96P69 | |
| DQRFRFPSPILKVQY | 101 | Q15291 | |
| FSKPRFVYLELPAAA | 1176 | P78509 | |
| LQSYKRDSVLRPFPA | 31 | Q8N5Y8 | |
| FPLTFGEKPALRSVY | 161 | Q6PEZ8 | |
| RARESYKYFPSSLSP | 211 | Q9P0U4 | |
| PFDSLSRYIFEKPRI | 1636 | Q6WRI0 | |
| YLQFKAEPPLTSRGF | 1291 | Q6ZP82 | |
| PQIFYSLSPSRRNFE | 31 | Q9BWC9 | |
| PRRLKESFRDPYSAF | 736 | Q5THR3 | |
| YKSFLFDKRPLSPAL | 406 | Q6ZN84 | |
| PFSSLFPKVEYIARA | 341 | Q86TI2 | |
| NFPPKSYLLRTSRES | 1091 | Q5JV73 | |
| PFRLRNLFSATFPTR | 1246 | Q5JV73 | |
| FLTALRAPKPTLRYF | 241 | P14061 | |
| RAPKPTLRYFTTERF | 246 | P14061 | |
| LLFPPTYKFDRNSND | 241 | Q9BT40 | |
| KVSPTFFFLRASQPR | 916 | Q92771 | |
| FPDSARLPLTRSFYL | 16 | Q9NQ33 | |
| PAPRTTFLYLVNFNK | 1051 | Q9UHN6 | |
| LFAPSIKARFPAETY | 236 | Q02246 | |
| AYTPVSRKPSTFNLF | 591 | P35475 | |
| LDVNRKAESPPRFYF | 521 | P13612 | |
| PNIPYKRAFSSFVTL | 206 | Q8IYD2 | |
| PRFLYLGPFKDSATV | 356 | P55285 | |
| KRTLGPFYPSRLFDQ | 11 | P02489 | |
| NARYRTPKILEPTAF | 696 | Q14289 | |
| PDFASYPKDLRRFLL | 106 | Q7Z7M8 | |
| QYFSDPRLIKVLFPS | 1306 | Q9BY12 | |
| SPYKRDNTFFRESPV | 121 | Q8NEY8 | |
| FPKRTSPARGYELLF | 646 | O60716 | |
| SFINSIRRAINKYPP | 2161 | A6NMZ7 | |
| LTPTLNPFIYSFRNK | 281 | Q8NGZ0 | |
| KPNSLYYFRLAARSP | 576 | P23468 | |
| DRSRLPKSPPYTAFL | 86 | P23588 | |
| PTSRLRYSRFLDPSN | 26 | A6NHM9 | |
| YFFRVRNPTKDLTNP | 311 | O60478 | |
| DNPVIRSYFKRADPF | 776 | Q9NQT8 | |
| PTPSIYLENKRDAFF | 886 | O14607 | |
| TFPKASFSDTLRPYF | 436 | O00635 | |
| SYLPRESFKPRREYQ | 46 | Q8IYX7 | |
| KSRRLPVLNASYGPF | 86 | Q14C87 | |
| TRELLSPYSPVLKFF | 236 | Q9Y519 | |
| LTPRSALLYKFNGSP | 996 | P28749 | |
| KLYRYSPQSFLPDST | 216 | Q9HCM1 | |
| APTRPLQRKQLYSFF | 621 | Q6ZNJ1 | |
| NYSFEELRFASPTPK | 2381 | O75592 | |
| FTPSESQRFSRRPYL | 16 | Q99935 | |
| PNLLTFYRKSSRKPS | 151 | Q8NHX4 | |
| RFFIDRPSTYFRPIL | 76 | Q9BQ13 | |
| GRFTFTLYLETPKPS | 136 | Q13046 | |
| KRSLEAYFAIQPRPS | 286 | Q15319 | |
| PRLKTPMYFFLRNFS | 51 | A6NF89 | |
| KRPTASQALRYPYFQ | 271 | Q9UPZ9 | |
| LYKTSFRVDVPFDLP | 266 | P51800 | |
| LYKTSFRVDVPFDLP | 266 | P51801 | |
| RKSSRRFVIFPIQYP | 36 | Q7LG56 | |
| AIARFFPKPYDDSRL | 2706 | Q63HN8 | |
| FPSSGRQSFYRNPIK | 251 | P56180 | |
| YVLSRRPDPATNKSF | 326 | Q8TDR2 | |
| ATVFKSPRTPPQRFY | 51 | Q14CS0 | |
| AAQFRKSYDSLYPPL | 1516 | Q9C0A1 | |
| SQRYAKVPLFSPNFS | 726 | Q9BQ52 | |
| KYDAKFTDFSLPPSR | 146 | Q9UHK0 | |
| KRCFLFPRYKFTSTP | 41 | Q0ZLH3 | |
| FPRYKFTSTPFTLKD | 46 | Q0ZLH3 | |
| ALPAPDRKRFSLQSY | 1201 | Q5XPI4 | |
| AFYTPKLRSAPRAFA | 271 | Q9P253 | |
| VLKRQYTSFFRPGLP | 336 | Q9NWM0 | |
| VPRFFRINPTPTYKS | 321 | Q6P2S7 | |
| LTDPFDTPAFNKLYR | 416 | O43847 | |
| KADRPFIYFLREPNT | 376 | A8MV23 | |
| DSYPRFLKSPAYRDL | 166 | O15492 | |
| KAFRYHPSFRTPQRD | 171 | Q9UC07 | |
| SPYFPTTARKLISDF | 716 | Q9Y6R1 | |
| SYDLAPFRISRFPSL | 371 | Q9P0Z9 | |
| LLFKFSSRYPFDSPQ | 56 | Q96B02 | |
| KFTYLGSQDRARPPS | 296 | Q7Z2W4 | |
| DPRYKRLPFLSAFER | 476 | O96006 | |
| PSEFKTQIQRYAPRF | 336 | O75604 | |
| FFTPPASKGNYSRRE | 1706 | Q69YN4 | |
| KSRRYFSSNPISLPV | 441 | Q5SRH9 | |
| PQKPVSAYALFFRDT | 261 | O94900 | |
| LRFLSTFKPPAYEDV | 116 | Q96G27 | |
| TYLRFFPPLQKQESE | 1421 | Q5VZL5 | |
| IYPTFESSRRNPFQK | 411 | Q6EMB2 | |
| FYVRPSPAKRRLSTL | 31 | Q9NYB0 | |
| RDKSYAGPLPIFNRS | 111 | Q8WTX9 | |
| FFKSLSSPKIRRYPL | 981 | B1ANS9 | |
| RIQRPFSVKFDPYTL | 481 | P07101 | |
| LLDKPVFSFYLNRDP | 211 | O96009 | |
| QTFSLARPKYFFPST | 716 | Q86TC9 |